3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
2
Completed
2
Recruiting
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Lymphoid
2
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Conditions
Breast Neoplasms
14
Neoplasms
11
Carcinoma, Non-Small-Cell Lung
10
Colorectal Neoplasms
9
Prostatic Neoplasms
8
Lung Neoplasms
7
Melanoma
6
Pancreatic Neoplasms
5
Head and Neck Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Neoplastic Cells, Circulating
4
Hematologic Neoplasms
4
Stomach Neoplasms
3
Neoplasm Metastasis
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Glioblastoma
3
Carcinoma, Hepatocellular
3
Uterine Cervical Neoplasms
2
Thyroid Neoplasms
2
Sarcoma
2
Recurrence
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Liver Diseases
2
Kidney Neoplasms
2
Glioma
2
Fibrosis
2
Interventions
Cyclophosphamide
27
Rituximab
20
Etoposide
14
Cytarabine
13
Melphalan
11
Vincristine
10
fludarabine
9
Prednisone
9
Doxorubicin
9
Busulfan
8
Peripheral Blood Stem Cell Transplantation
7
Radiotherapy
6
Filgrastim
6
Cyclosporine
6
Bendamustine Hydrochloride
6
fludarabine phosphate
5
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
5
Mycophenolic Acid
5
Cisplatin
5
tositumomab I-131
4
ibritumomab tiuxetan
4
Ifosfamide
4
Dexamethasone
4
Carmustine
4
relmacabtagene autoleucel
3
Thiotepa
3
Indium
3
Immunotherapy, Adoptive
3
Gemcitabine
3
Drug Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Lymphoma, Non-Hodgkin
×
Blood Specimen Collection
×
Clear all
NCT05735704
2025-03-26
SANGUINE
JaxBio Ltd
Unknown
3,000 enrolled
NCT05422521
2024-01-30
CART-Omic
Centre Hospitalier Universitaire de Nice
Phase NA
Unknown
20 enrolled